Q1 Earnings Estimate for ALNY Issued By Leerink Partnrs
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Alnylam Pharmaceuticals in a research note issued on Wednesday, April 2nd. Leerink Partnrs analyst M. Foroohar now forecasts that the biopharmaceutical company will earn ($0.74) per share for the quarter, down from their […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Alnylam Pharmaceuticals in a research note issued on Wednesday, April 2nd. Leerink Partnrs analyst M. Foroohar now forecasts that the biopharmaceutical company will earn ($0.74) per share for the quarter, down from their […]
